Aquestive Therapeutics, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 3.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 488.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company’s proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.
Details
| Name | Aquestive Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 147 |
| Founded | 2004 |
| Ipo Date | 2018-07-25 |
| Ceo | Daniel Barber |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US03843E1047 |
| Cusip | 03843E104 |
| Cik | 0001398733 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Daniel Barber | Chief Executive Officer, President and Director |
| A. Ernest Toth Jr. | Senior Vice President and Chief Financial Officer |
| Lori J. Braender BSBA, Esq., J.D. | Corporate Secretary |
| Cassie Jung | Chief Operating Officer |
| Thomas A. Zalewski | Chief Legal Officer and Chief Compliance Officer |
| Peter E. Boyd | Senior Vice President of Information Technology and Chief People Officer |
| Dr. Matthew Greenhawt B.Sc., M.B.A., M.D. | Chief Medical Officer |
| Sherry Korczynski | Chief Commercial Officer |
| Dr. Melina T. Cioffi Pharm.D. | Senior Vice President of Regulatory Affairs |
| Dr. Matthew William Davis M.D., R.Ph. | Chief Development Officer |
Contact
| Address | 30 Technology Drive, Warren, New Jersey 07059, United States |
| Phone | 908 941 1900 |
| Website | https://www.aquestive.com |